Wu, C.-P.; Hung, T.-H.; Hsiao, S.-H.; Huang, Y.-H.; Hung, L.-C.; Yu, Y.-J.; Chang, Y.-T.; Wang, S.-P.; Wu, Y.-S.
Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. Cancers 2020, 12, 1366.
https://doi.org/10.3390/cancers12061366
AMA Style
Wu C-P, Hung T-H, Hsiao S-H, Huang Y-H, Hung L-C, Yu Y-J, Chang Y-T, Wang S-P, Wu Y-S.
Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. Cancers. 2020; 12(6):1366.
https://doi.org/10.3390/cancers12061366
Chicago/Turabian Style
Wu, Chung-Pu, Tai-Ho Hung, Sung-Han Hsiao, Yang-Hui Huang, Lang-Cheng Hung, Yi-Jou Yu, Yu-Tzu Chang, Shun-Ping Wang, and Yu-Shan Wu.
2020. "Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs" Cancers 12, no. 6: 1366.
https://doi.org/10.3390/cancers12061366
APA Style
Wu, C.-P., Hung, T.-H., Hsiao, S.-H., Huang, Y.-H., Hung, L.-C., Yu, Y.-J., Chang, Y.-T., Wang, S.-P., & Wu, Y.-S.
(2020). Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. Cancers, 12(6), 1366.
https://doi.org/10.3390/cancers12061366